[The influence of orally applied iproveratril (Verapamil) on coronayy blood flow, oxygen consumption and carbon dioxide formation in the human heart].
D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D001794:Blood Pressure; D002245:Carbon Dioxide / Q000096:biosynthesis; D003331:Coronary Vessels / Q000187:drug effects / Q000503:physiopathology; D006321:Heart / Q000187:drug effects; D006331:Heart Diseases / Q000188:drug therapy / Q000503:physiopathology; D006801:Humans; D009206:Myocardium / Q000378:metabolism*; D009570:Nitriles / Q000494:pharmacology*; D010101:Oxygen Consumption; D014665:Vasodilator Agents / Q000494:pharmacology*; D014700:Verapamil / Q000494:pharmacology
D000889:Anti-Arrhythmia Agents; D009570:Nitriles; D014665:Vasodilator Agents; D002245:Carbon Dioxide; D014700:Verapamil
Der Einfluss von oral verabreichtem Iproveratril (Verapamil) auf Coronardurchblutung, sauerstoffverbrauch und Kohlendioxydbildung des menschlichen Herzens.